Vizyon Pharmaceuticals Private Limited, a active private limited company, was established on 22 March 2017 in Nagpur, Maharashtra, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299MH2017PTC292842. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sandip Prakashrao Kukse (Director), Neelima Kukse (Director). Past directors included Devidas Shripatrao Kukse, Manish Prakashrao Kukse, Sandip Prakashrao Kukse. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 313-B Gandhi Puitala Chowk Garud Khamb Sudama Road, Beside Shree Tusion Classes, Nagpur, Maharashtra, 440002.
U24299MH2017PTC292842
292842
22 March 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vizyon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandip Prakashrao Kukse | Director | 03 Jul 2017 | Current |
| Neelima Kukse | Director | 03 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jul 2017 | Past |
| Pramod Abcsdd | Director | 03 Jul 2017 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 15 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vizyon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.25% increase. The company also saw a substantial improvement in profitability, with a 109.26% increase in profit. The company's net worth Soared by an impressive increase of 45.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Vizyon Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2025 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Vizyon Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vizyon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vizyon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Vizyon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Vizyon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 101097800 was registered on 26 Mar 2025. was documented.
The activity Sandip Prakashrao Kukse was appointed as a Director was appointed as a Director on 03 Jul 2017 & has been associated with this company since 8 years 5 months . was completed.
Neelima Kukse was appointed as a Director was appointed as a Director on 03 Jul 2017 & has been associated with this company since 8 years 5 months . was recorded as a recent event.
Progress on Vizyon Pharmaceuticals Private Limited was registered on 22 Mar 2017 with Roc Mumbai & aged 8 years 8 months as per MCA records. was documented.
The CIN of Vizyon Pharmaceuticals Private Limited is U24299MH2017PTC292842.
Vizyon Pharmaceuticals Private Limited is headquartered at 313-B Gandhi Puitala Chowk Garud Khamb Sudama Road, Beside Shree Tusion Classes, Nagpur, Maharashtra, 440002.
Vizyon Pharmaceuticals Private Limited was incorporated on 22 March 2017.
The current directors of Vizyon Pharmaceuticals Private Limited are
The primary industry of Vizyon Pharmaceuticals Private Limited is Trade.
Vizyon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Vizyon Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Vizyon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX